Source: precisionmedicinegrp.com

Press Release: ProMedDx : Precision for Medicine launches biospecimen solutions offering with acquisition of ProMedDx and GLAS

Precision for Medicine, part of Precision Medicine Group, announced it has acquired leading biospecimen providers ProMedDx and GLAS, significantly expanding its capabilities and expertise in the biospecimen solutions space. With the acquisitions, Precision now offers an unmatched level of scientific understanding, high-quality specimen solutions, and global scale.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Jim Boushell's photo - Co-Founder & CEO of ProMedDx

Co-Founder & CEO

Jim Boushell

CEO Approval Rating

90/100

Read more